How to Fight a Denial for a Wheelchair, Prosthetic Limb, or Other DME

Durable medical equipment (DME) — power wheelchairs, prosthetic limbs, hospital beds, custom orthotics, patient lifts — is denied at staggering rates, even when medically necessary. Insurers routinely claim that a cheaper device would suffice, that you don't meet "functional criteria," or that documentation is incomplete. These denials happen because DME is expensive, because coverage rules are byzantine (especially the Medicare Local Coverage Determinations that commercial insurers often mirror), and because payers count on patients and suppliers giving up. But the same complexity that enables denials also creates leverage: when you cite the correct LCD, the correct K-level definition, and the correct MRADL (Mobility-Related Activities of Daily Living) framework, many denials crumble. This guide walks you through the most common denial templates, the specific policies and evidence that overturn them, and how to structure an appeal that gets reviewed seriously.

---

Why Insurers Deny DME

Denials for wheelchairs, prosthetics, and other DME cluster around five recurring templates. Recognizing your denial type helps you choose the right counter-argument.

1. "A less costly alternative is sufficient"

The most common DME denial. Insurer claims a cane or walker would work instead of a power wheelchair, a manual wheelchair instead of a power chair, a Group 2 power chair instead of Group 3 complex rehab technology, or a mechanical prosthetic knee instead of a microprocessor knee. This denial ignores the hierarchical evaluation required by NCD 280.3 and the specific functional criteria in the relevant LCD.

2. "Does not meet functional criteria / K-level / MRADL requirements"

For prosthetic limbs, the insurer asserts you're "only" K2 when your prosthetist documented K3 or K4 function. For power wheelchairs, the insurer says you haven't proven impairment in Mobility-Related ADLs in the home (toileting, feeding, dressing, grooming, bathing). These denials misread or ignore the clinical documentation in your ATP (Assistive Technology Professional) evaluation or prosthetic assessment.

3. "Not medically necessary / experimental / cosmetic"

Used to deny high-end technology: microprocessor knees (C-Leg, Genium, Rheo Knee), myoelectric upper-limb prostheses (i-Limb, bebionic), Group 3 power wheelchairs with tilt/recline, or air-fluidized pressure surfaces. The insurer characterizes proven, FDA-cleared devices as "investigational" or labels functional benefit as mere "convenience."

4. "Documentation incomplete / no face-to-face / no home assessment"

Technical denials. CMS and most commercial payers require a face-to-face examination by the prescribing practitioner within six months of the order, a Standard Written Order (SWO), a Detailed Product Description (DPD), and for power mobility devices, proof of in-home usability via home assessment. Missing any piece triggers a blanket denial, even when medical necessity is obvious.

5. "Patient has potential to improve / skilled therapy should be tried first"

The notorious "improvement standard" — the mistaken belief that Medicare (and by extension, commercial plans) only covers devices if a patient is improving, not maintaining function. This was explicitly rejected by the Jimmo v. Sebelius settlement in 2013, yet improvement-standard language persists in denial letters, especially for hospital beds, pressure surfaces, and wheelchairs for progressive neurologic conditions (ALS, MS, muscular dystrophy).

---

The Citations Insurers Respect

DME appeals succeed when you anchor your argument in named Local Coverage Determinations, National Coverage Determinations, and published functional frameworks. Do not rely on general "medical necessity" language. Cite these documents by name and year.

Medicare Local Coverage Determinations (LCDs)

Medicare Administrative Contractors (MACs) issue LCDs that define coverage criteria for DME within their jurisdiction. Commercial insurers frequently adopt these standards verbatim. Your appeal must cite the LCD that governs your device and your region. The most important LCDs:

• LCD L33788 – Power Mobility Devices (Noridian and CGS; updated periodically)

The central LCD for power wheelchairs (Group 2 and Group 3) and scooters. Defines the algorithmic evaluation (cane → walker → manual wheelchair → power device), MRADL requirements, face-to-face exam, Standard Written Order (SWO), Detailed Product Description (DPD), and home assessment. If you were denied a power wheelchair, this is your primary citation.

• LCD L33789 – Manual Wheelchair Bases (Noridian and CGS)

Covers standard, lightweight, and ultralight manual wheelchairs. Specifies when each category is covered based on self-propulsion ability, arm/shoulder function, and home use.

• LCD L33686 – Lower Limb Prostheses (Noridian and CGS)

Defines K-levels (K0 through K4) and coverage criteria for prosthetic feet, knees (mechanical vs. microprocessor), and sockets. Microprocessor knees require documented K3 or K4 functional level. This LCD is the foundation of any prosthetic-limb appeal.

• LCD L33797 – Hospital Beds and Accessories (Noridian and CGS)

Covers semi-electric and full-electric hospital beds. Specifies qualifying conditions: immobility requiring bed positioning, stage 3–4 pressure ulcers, severe respiratory/cardiac conditions requiring head/chest elevation >30°, and others.

• LCD L33800 – Pressure Reducing Support Surfaces, Group 2 (Noridian and CGS)

Powered pressure-reducing mattresses for patients with stage 3–4 ulcers who have not healed on a Group 1 surface.

• LCD L33790 – Pressure Reducing Support Surfaces, Group 3 (Noridian and CGS)

Air-fluidized beds for patients with large or multiple stage 3–4 ulcers who have failed Group 2 surfaces and are under physician-directed comprehensive wound care.

• LCD L33792 – Wheelchair Options and Accessories (Noridian and CGS)

Covers power tilt, power recline, power elevating leg rests, and seat elevation systems. Critical for Group 3 complex rehab denials.

(Note: If you have a different MAC — for example, First Coast [J-N] or Palmetto [J-J] — check for corresponding LCD numbers; the content is often identical but the LCD identifier may differ. Noridian [J-A, J-D] and CGS [J-B, J-C] cover most of the U.S.)

National Coverage Determinations (NCDs)

• NCD 280.3 – Mobility Assistive Equipment (2005)

Foundational CMS policy. Requires hierarchical evaluation: beneficiaries must have documentation showing why each less costly mobility device (cane, walker, manual wheelchair, scooter) is insufficient before a power wheelchair is covered. Also defines MRADL and in-home use requirements.

The Jimmo Settlement (2013)

• Jimmo v. Sebelius Settlement Agreement (2013, CMS manual updates 2014)

Class-action settlement clarifying that Medicare coverage is not conditioned on potential for improvement. Maintenance therapy and devices that prevent decline are covered when reasonable and necessary. If your denial letter says "no potential for improvement" or "therapy should restore function first," cite Jimmo by name.

Functional Classification Systems

• K-Levels (Medicare Functional Classification Levels)

Defined in LCD L33686 and the Medicare Benefit Policy Manual Ch. 15 §140:

- K0: Does not have the ability or potential to ambulate or transfer safely with or without assistance.

- K1: Has ability or potential to use prosthesis for transfers or ambulation on level surfaces at fixed cadence (limited and unlimited household ambulator).

- K2: Has ability or potential for ambulation with variable cadence (limited community ambulator).

- K3: Has ability or potential for ambulation with variable cadence and ability to traverse most environmental barriers (community ambulator).

- K4: Has ability or potential for prosthetic ambulation that exceeds basic ambulation skills; high-impact, stress, or energy demands (athlete, active adult).

Microprocessor knees (C-Leg, Genium, Rheo Knee) require documented K3 or K4 function.

• MRADL (Mobility-Related Activities of Daily Living)

Defined in NCD 280.3 and LCD L33788. The five MRADLs are:

1. Toileting

2. Feeding

3. Dressing

4. Grooming

5. Bathing

Coverage requires impairment in at least one MRADL in the home that cannot be adequately addressed by a cane or walker.

Professional Certifications

• RESNA ATP (Assistive Technology Professional) and SMS (Seating and Mobility Specialist)

While not strictly required by Medicare, an evaluation by a RESNA-certified ATP/SMS carries significant weight in Group 3 power wheelchair and complex seating appeals. Many commercial plans' medical policies reference ATP involvement as "recommended" or "preferred."

---

How to Argue Against Each Denial Reason

1. "A less costly alternative is sufficient"

Why this denial is wrong:

NCD 280.3 mandates a hierarchical mobility evaluation. The prescriber must document why each less expensive device fails to meet your functional needs in your home. If the insurer says "a manual wheelchair is sufficient" but your physician documented that you cannot self-propel a manual chair due to upper-extremity weakness, shoulder pain, or cardiopulmonary limitations, the denial contradicts the clinical record.

Concrete appeal steps:

• Cite NCD 280.3 and LCD L33788 by name. Quote the hierarchical evaluation requirement and the MRADL framework.
• Attach a letter from your physician (ideally physiatry, neurology, or the specialist who did the face-to-face exam) that methodically walks through each device level:

- Cane: tried [dates], insufficient because [specific reason: fall risk, instability, can't reach bathroom in time].

- Walker: tried [dates], insufficient because [cannot propel due to upper-extremity fatigue, unsafe on carpet].

- Manual wheelchair: tried [dates], cannot self-propel due to [bilateral upper-extremity weakness from MS/SCI/CP, shoulder pain, cannot navigate home turning radius].

- Scooter: insufficient because [cannot transfer independently, cannot operate tiller due to hand weakness, home layout requires tight turns].

- Therefore, Group 2 or Group 3 power wheelchair is medically necessary.

• For Group 3 denials (insurer says Group 2 power chair is enough): Cite LCD L33792 and document why power tilt, recline, or other Group 3 features are necessary (pressure relief due to inability to weight-shift, severe spasticity requiring seating accommodation, progressive condition like ALS where power seat functions are necessary to maintain upright posture as disease advances). Include ATP letter with measurements, turning radius, and seating-system justification.

• For microprocessor knee denials (insurer says mechanical knee is enough): Cite LCD L33686 and document your K3 or K4 function. Attach letter from prosthetist with observed gait analysis, variable-cadence walking, stair negotiation, community ambulation, employment, or sports participation. Emphasize safety (reduced fall risk with microprocessor stance control), energy efficiency, and functional outcomes published in peer-reviewed literature (e.g., reduced oxygen cost, improved balance). Many commercial policies specifically cover microprocessor knees for K3+ amputees; quote your plan's prosthetic policy if available.

• For myoelectric prosthesis denials: Document work/vocational requirements, bimanual tasks (cooking, typing, child care), and failure of body-powered device to meet these needs. Cite any plan language on "functional benefit" and ATP/occupational therapy eval showing successful training with myoelectric components.

2. "Does not meet functional criteria / K-level / MRADL requirements"

Why this denial is wrong:

Payers often deny based on a shallow paper review, ignoring detailed clinical documentation. A claims reviewer sees "wheelchair user" and assumes K1 or K2 for a prosthetic patient, or assumes no MRADL impairment because the patient is not bedbound.

Concrete appeal steps:

• Resubmit the ATP or prosthetist evaluation, highlighted. For power wheelchairs, circle/highlight every sentence documenting MRADL impairment (e.g., "cannot reach toilet in time due to mobility limitation"; "cannot prepare meals due to standing intolerance <2 min"; "cannot don/doff clothing without wheelchair access to bedroom").

• For K-level denials: Attach a letter from the prosthetist with observed functional evidence: "Patient ambulates ½ mile on level surfaces, navigates stairs with rail, crosses streets at variable cadence, returns to work as [occupation], plays adaptive sports." Cite the K3 or K4 definition verbatim from LCD L33686. If the prosthetist documented K3 function and the payer's reviewer said K2, point out the contradiction explicitly: "The denial states '[patient is limited community ambulator, K2].' This contradicts the clinical evaluation by [prosthetist name], who documented that the patient ambulates at variable cadence, traverses curbs and uneven terrain, and has returned to full-time employment—meeting K3 criteria per LCD L33686."

• For MRADL denials: Emphasize that MRADL impairment is assessed in the home, not clinic or hospital. If you live alone, document how you cannot perform toileting or feeding without the requested device. If you have a caregiver, document the burden and why independence is critical. Cite the face-to-face exam note explicitly: "Face-to-face exam by Dr. [name] on [date] documented: '[quote verbatim].' This satisfies MRADL criteria under NCD 280.3."

3. "Not medically necessary / experimental / cosmetic"

Why this denial is wrong:

Microprocessor knees, myoelectric hands, Group 3 power wheelchairs with tilt/recline, and air-fluidized beds are FDA-cleared, covered in published LCDs, and supported by clinical evidence. Denials citing "investigational" or "cosmetic" status are factually incorrect.

Concrete appeal steps:

• Cite the relevant LCD showing the device is a covered benefit. For microprocessor knees, cite LCD L33686 and the HCPCS code (e.g., L5856 for C-Leg, L5857 for other microprocessor knees). For power tilt/recline, cite LCD L33792. For air-fluidized beds, cite LCD L33790.

• Attach published evidence:

- For microprocessor knees: cite studies showing reduced fall risk, improved mobility, reduced energy expenditure (e.g., Hafner et al., Prosthetics and Orthotics International 2007; Bellmann et al., Gait & Posture 2010).

- For myoelectric prostheses: cite studies on functional improvement and return to work/ADLs (e.g., Biddiss & Chau, Prosthetics and Orthotics International 2007).

- For Group 3 wheelchairs with power tilt: cite pressure-relief literature and positioning needs for progressive neurologic conditions (e.g., Consortium for Spinal Cord Medicine Pressure Ulcer Prevention guidelines).

• Rebut "cosmetic" claims explicitly: "The denial characterizes a myoelectric prosthesis as 'cosmetic.' This is incorrect. The device enables bimanual ADLs (meal prep, typing, child care) documented in the occupational therapy evaluation and is necessary for the patient's employment as [job]. Cosmetic refers to passive devices with no functional capability; this device is active and functional."

• If the denial cites an internal medical policy that contradicts the LCD, point out the contradiction: "The denial cites [Plan Policy XYZ] stating microprocessor knees are 'investigational.' This contradicts Medicare LCD L33686, which establishes coverage criteria for microprocessor knees for K3+ amputees. [Plan name] is required to cover Medicare-covered items for Medicare Advantage enrollees. For commercial enrollees, the Plan's policy is inconsistent with the standard of care and published evidence."

4. "Documentation incomplete / no face-to-face / no home assessment"

Why this denial is wrong:

Often the documentation was submitted but not reviewed, or the payer uses an outdated standard (e.g., "7-element order" rather than the current Standard Written Order).

Concrete appeal steps:

• Confirm the face-to-face exam occurred within 6 months of the order and is documented in the medical record. Attach the exam note with the date, your diagnosis, and the mobility assessment. Cite the face-to-face requirement from LCD L33788 (for power mobility) or the relevant LCD for your device.

• Confirm the Standard Written Order (SWO) is complete. Per the 21st Century Cures Act (implemented 2020), the SWO must include:

- Beneficiary name

- Order date

- Detailed item description (narrative or HCPCS)

- Prescriber name, NPI, and signature

- Quantity

If the denial cites "missing 7-element order," note that this is outdated: "The denial states the order does not meet the '7-element order' requirement. This standard was replaced by the Standard Written Order (SWO) requirement in 2020 per the 21st Century Cures Act. The attached SWO dated [date] meets all current CMS requirements."

• For power mobility, confirm home assessment is included. Attach the ATP home-assessment form showing doorway widths, turning radius, floor surfaces, entry/exit access, and in-home MRADL locations (bathroom, kitchen, bedroom). If the denial says "no home assessment," write: "Home assessment was performed by [ATP name, RESNA certification] on [date] and submitted with the initial claim. Reattached here. Per LCD L33788, the assessment documents in-home usability and accessibility."

• Attach the Detailed Product Description (DPD) signed and dated by the prescriber, especially for Group 3 power wheelchairs and complex seating systems.

• If any document was missing, obtain it now and submit with the appeal, along with an explanation: "The initial submission inadvertently omitted [document]. It is attached here. All coverage criteria under [LCD name] are now satisfied."

5. "Patient has potential to improve / skilled therapy should be tried first"

Why this denial is wrong:

This is the improvement standard, rejected by the Jimmo v. Sebelius settlement. Medicare and most commercial plans must cover devices and services that maintain function or prevent/slow decline, not only those that restore function.

Concrete appeal steps:

• Cite Jimmo by name: "The denial states '[patient has no potential for improvement]' and suggests therapy should be tried first. This reflects the discredited 'improvement standard.' Under the Jimmo v. Sebelius settlement (2013) and CMS manual updates (2014), Medicare coverage does not require potential for improvement. Maintenance of function and prevention of decline are covered when reasonable and necessary."

• Attach supporting documentation from your physician explaining why maintenance is medically necessary. For example:

- ALS patient: "Progressive neuromuscular disease; power wheelchair with tilt/recline is necessary to maintain safe mobility and upright posture as disease advances. Therapy cannot restore function but equipment prevents secondary complications (pressure ulcers, aspiration, falls)."

- Pressure ulcer: "Stage 3 sacral ulcer post-flap surgery; full-electric hospital bed is necessary to maintain head-of-bed elevation and prevent recurrence. Patient's mobility status is stable; improvement is not the goal. Goal is wound maintenance and prevention of further breakdown."

• For hospital beds and pressure surfaces, cite LCD L33797 or LCD L33800/L33790 showing that coverage criteria do not include "potential for improvement." The criteria are clinical (stage 3–4 ulcer, immobility, cardiopulmonary positioning needs), not functional prognosis.

• If therapy was already tried, document it: "The denial suggests therapy. The patient completed 12 weeks of physical therapy [dates] with [therapist name]. Therapy improved [specific outcome] but did not eliminate the need for [DME]. The device is necessary for long-term function maintenance."

---

What We Do

We build AI-drafted appeal letters for patients, families, DME suppliers, ATPs, and prosthetists fighting wheelchair, prosthetic, and DME denials. You answer intake questions about your diagnosis, MRADL impairment, prior devices tried, ATP or prosthetist evaluation, and K-level (for prosthetics). Our system generates a physician-ready appeal letter citing the correct LCD (L33788, L33686, L33797, etc.), the correct NCD 280.3 hierarchical framework, and the correct rebuttal to your denial reason—whether it's "less costly alternative," missing documentation, improvement standard, or K-level dispute. You review, your physician signs, and you submit. The letter is firm, specific, and built for the reviewer who actually knows the LCD.

---

Sources

1. CMS Local Coverage Determinations (LCDs), available at https://www.cms.gov/medicare-coverage-database:

- LCD L33788 – Power Mobility Devices (Noridian, CGS)

- LCD L33789 – Manual Wheelchair Bases (Noridian, CGS)

- LCD L33686 – Lower Limb Prostheses (Noridian, CGS)

- LCD L33797 – Hospital Beds and Accessories (Noridian, CGS)

- LCD L33800 – Pressure Reducing Support Surfaces, Group 2 (Noridian, CGS)

- LCD L33790 – Pressure Reducing Support Surfaces, Group 3 (Noridian, CGS)

- LCD L33792 – Wheelchair Options and Accessories (Noridian, CGS)

2. CMS National Coverage Determination (NCD) 280.3 – Mobility Assistive Equipment (2005), available at https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=219

3. Jimmo v. Sebelius Settlement Agreement (January 2013) and CMS manual updates (2014), summary at https://www.cms.gov/medicare/coverage/determin/jimmo-settlement

4. Medicare Benefit Policy Manual, Chapter 15 §140 – Functional Classification Levels (K-levels), available at https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/bp102c15.pdf

5. Hafner BJ, Willingham LL, Buell NC, et al. "Evaluation of function, performance, and preference as transfemoral amputees transition from mechanical to microprocessor control of the prosthetic knee." Archives of Physical Medicine and Rehabilitation 2007;88(2):207-17.

6. Bellmann M, Schmalz T, Blumentritt S. "Comparative biomechanical analysis of current microprocessor-controlled prosthetic knee joints." Archives of Physical Medicine and Rehabilitation 2010;91(4):644-52.

7. Biddiss EA, Chau TT. "Upper limb prosthesis use and abandonment: a survey of the last 25 years." Prosthetics and Orthotics International 2007;31(3):236-57.

8. Consortium for Spinal Cord Medicine. "Preservation of upper limb function following spinal cord injury: a clinical practice guideline for health-care professionals." Journal of Spinal Cord Medicine 2005;28(5):434-70.

9. Rehabilitation Engineering and Assistive Technology Society of North America (RESNA). ATP and SMS Certification standards, available at https://www.resna.org/certification